Close

Sarepta (SRPT) PT Raised to $76 at Oppenheimer Amid Eteplirsen Approval

Go back to Sarepta (SRPT) PT Raised to $76 at Oppenheimer Amid Eteplirsen Approval
SAREPTA THERAP (NASDAQ: SRPT) Delayed: 116.96 --0 (-0%)
Previous Close $116.96    52 Week High $63.73 
Open $116.96    52 Week Low $8.00 
Day High $116.96    P/E N/A 
Day Low $116.96    EPS $-5.69 
Volume 891